Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis

  title={Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis},
  author={Melissa Sum and Franco Vallejo Garcia},
Combination therapy with nivolumab, an anti-programmed cell death-1 antibody, and ipilimumab, an anti-cytotoxic T-lymphocyte-associated antigen4 compared to ipilimumab alone leads to significantly longer overall survival in patients with advanced melanoma [1]. Endocrinopathies associated with immunotherapy include hypophysitis, thyroid dysfunction, adrenal… CONTINUE READING